Negative Pressure Wound Therapy Market Will Likely to Expand at a Steady CAGR of 6.6% by 2026

Negative-Pressure Wound Therapy (NPWT) is a therapeutic technique (or) sealed wound-care system that involves usage of a vacuum dressing to promote healing of large chronic persistent wounds and acute complicated wounds. NPWT is also used for rapid healing of second- and third-degree burns. The system consists of an electronically controlled pump and a foam dressing that drains the wound. An adjustable negative pressure is applied via an airtight adhesive film that covers the wound. NPWT drains wound exudate and helps to promote blood circulation and healing. The global NPWT market has been segmented on the basis of product type, end user and region.
The global NPWT market has been estimated to be valued at US$ 1,822.5 Mn by 2016 end, and is expected to expand at a 6.6% CAGR over the forecast period (2016–2026).

The global NPWT market is segmented on the basis of product and end user.

Based on product type, the market has been segmented into stand-alone NPWT devices, portable NPWT devices, single use disposable NPWT devices and NPWT accessories (Canisters). Single use disposable NPWT devices segment, followed by the portable NPWT devices segment, is expected to account for highest demand for NPWT devices over the forecast period.
Based on end user, the market has been segmented into hospitals, clinics and home care settings. The hospitals segment currently accounts for highest revenue share of the NPWT devices market. NPWT is also gaining importance in home care settings owing to its cost effectiveness when compared to the cost of staying in a hospital.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-810

Summary of Table of Content:
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Global Negative Pressure Wound Therapy Market Overview
5. Global Negative Pressure Wound Therapy Market Analysis, By Product Type
6. Global Negative Pressure Wound Therapy Market Analysis, By End User
7. Global Negative Pressure Wound Therapy Market Analysis, By Region
8. North America Negative Pressure Wound Therapy Market Analysis
9. Latin America Negative Pressure Wound Therapy Market Analysis
10. Western Europe Negative Pressure Wound Therapy Market Analysis
11. Eastern Europe Negative Pressure Wound Therapy Market Analysis
12. APEJ Negative Pressure Wound Therapy Market Analysis
13. Japan Negative Pressure Wound Therapy Market Analysis
14. MEA Negative Pressure Wound Therapy Market Analysis
15. Competition Landscape

Request to Browse Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/negative-pressure-wound-therapy-market/toc

Acoustic Neurinoma Treatment Market to Perceive Substantial Growth During 2017-2027

Acoustic Neurinoma is a noncancerous growth that develops on the cranial nerve. Acoustic Neurinoma also known as develops on the vestibulocochlear nerve or the eight cranial nerve which connects the inner ear with the brain. The vestibulocochlear nerve has two parts, one helps in sending balance information and other involved in transmitting sound from ear to the brain. Acoustic Neurinoma also known by the name neurolemmomas or vestibular schwannomas. Although acoustic neurinoma do not invade the brain, they may push on it as they grow. But they may be deadly, if they become large enough to press on the cerebellum or stem.

Acoustic Neurinoma Treatment Market: Drivers and Restraints

Acoustic neurinoma is expected to witness growth with the increasing number of government funding and also the introduction of new technologies. The UK government announced US$ 5.58 million funding to study the risk of brain tumor in relation to use of mobiles. As acoustic neurinoma is a rare disease, it has few market players, market expansion is the strategy used by the market players. For instance, Accuray Inc. signed an agreement with Christie InnoMed Inc. to market its CyberKnife and TomoTherapy System product portfolios in Canada.

Request Report TOC: https://www.futuremarketinsights.com/toc/rep-gb-3315

Acoustic Neurinoma Treatment Market: Overview

Acoustic neurinoma occurs in two forms, one is associated to a syndrome known by the name neurofibromatosis type II and other a sporadic form. Neurofibromatosis type II is characterized by the noncancerous growth in the nerve system. As this type is an inherited rare disease majority of the acoustic neurinoma occurs in the sporadic form. One of the reason of acoustic neurinoma is high exposure to radiation doses to the head and neck region. Acoustic neurinoma has three main courses of treatment: observation, surgical removal or radiation therapy.

As acoustic neurinoma is non-cancerous growth, some doctors monitor the tumor with the periodic MRI scans and suggests other treatments if it grows a lot and may cause serious problem. Translabyrinthine, retrosigmoid/sub-occipital and middle fossa are the three main surgical approaches for removing acoustic neurinoma. In case of radiation therapy, one of the two ways can be used: multi-session fractionated stereotactic radiotherapy and single fraction stereotactic radiosurgery.

Request Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3315

Acoustic Neurinoma Treatment Market: Region-wise Outlook

The report covers market scenario for North America, Europe, Asia Pacific, Latin America and MEA. As the market is niche there are very few players in the market giving opportunities for emerging players for market entry. As North America is strong in terms of international company presence and also strong research and development investments, the market is highest in this region. With the increasing number of approvals for robotic radiosurgery therapies, Asia Pacific is expected to be the fastest growing region. Accuray received Japanese approval to market its CyberKnife M6 System.

Acoustic Neurinoma Treatment Market: Key Market Participants

Accuray, Inc., Huiheng Medical, Inc., Elekta and Varian Medical Systems. The market is competitive in nature leading companies to focus on various new strategies such as, merger & acquisitions, new product development and expanding their operation in the new countries for maintaining their foothold in the market.

Pre Book Acoustic Neurinoma Treatment Market Research Report: https://www.futuremarketinsights.com/checkout/3315

Preclinical Imaging Market to Perceive Substantial Growth During 2017-2027

Preclinical Imaging is used for imagining of living animals specifically for research purposes, research can be for drug development and other types. Imaging products are very important so as to observe the changes in organs, cell or a tissue these changes are observed in animals that respond to environmental changes or physiological changes. Imaging modalities are mostly non-invasive and in vivo and are considered to be important for studying animal. There are different types of modalities which are used for preclinical imaging such as CT imaging, MRI imaging, PET/SPECT imaging, multimodal imaging, optical imaging, ultrasound imaging, and photoacoustic (PAT) imaging. Apart from above factors preclinical imaging market has huge growth potential and is expected to continue over the forecast period. Technological advancement in preclinical imaging and the increasing adoption of molecular imaging technology for drug development tool are some factors that are expected to drive the preclinical imaging market over the forecast period. Moreover, companies are into collaborations with the biotechnology and pharmaceutical companies to increase its geographical footprint globally which is expected to drive the global preclinical imaging market over the forecast period.

Request Report TOC: https://www.futuremarketinsights.com/toc/rep-gb-2816

Preclinical Imaging Market: Drivers and Restraints

The demand for preclinical imaging market is fueled by technical innovation and discretionary funding which is thereby expected to drive the demand for preclinical imaging market over the forecast period. In addition the increasing number of clinical research organizations (CROs), research and development institutes, biotechnology and pharmaceuticals companies and other end users are propelling demand for preclinical imaging products. Encouragement for research and development, huge investments by government for research and need for drug development is expected to witness robust market growth during the forecast period. Moreover increasing applications such as life sciences, cosmetic industry and others for preclinical products is another factor that is expected to drive growth of the global preclinical imaging market over the forecast period. However, high cost of preclinical imaging systems and lack of awareness regarding preclinical imaging technology is expected to impede revenue growth of the preclinical imaging market over the forecast period.

Preclinical Imaging Market: Overview

The preclinical imaging market, is largely penetrated by some global players and these players are creating opportunities for the tier 2 and tier 3 players by withdrawing their products from the market. Moreover the major players in the market are focusing on introducing technological advance products. Above mentioned factors are expected to witness robust CAGR over the forecast period. Moreover, increasing research and development for drug development and for identification of unknown agents that causes death is expected to fuel demand for preclinical imaging products such as CT, MRI and others.

Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2816

Preclinical Imaging Market: Regional Overview

Geographically, the global Preclinical Imaging Market, is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, Middle East and Africa (MEA).
North America dominates the global preclinical imaging market followed by Europe. North America and Western Europe regions are expected to witness robust growth due to increase in research and development and with the number of developed research infrastructure is expected to fuel the revenue growth in these regions. APEJ is expected to witness significant growth as compared to other regions and countries owing to government programs for preclinical imaging and funding for research and development expected to fuel market growth in this region. Moreover, rapidly expanding contract research organization in this region is expected to have a significant impact on the market growth. However, increasing research and educational institutes may boost the growth of preclinical imaging market in these regions during the forecast period.

Pre Book Preclinical Imaging Market Research Report: https://www.futuremarketinsights.com/checkout/2816

Preclinical Imaging Market: Key Players
Some of the players operating in the market for preclinical imaging market are Bruker Corporation, Thermo Fisher Scientific, General Electric, PerkinElmer, Inc., VisualSonics, Inc., MILabs B.V., Siemens A.G., TriFoil Imaging, Mediso Ltd., and Agilent Technologies and others.

Behavioral Health Market to Witness a Pronounce Growth During 2017 - 2027

Mental and emotional well-being of an individual is termed as behavioral health. It is the study of the behaviors, emotions, and biology related to an individual’s well-being as well as their ability to function daily task. The terms metal health and behavioral health are often used interchangeably. Personality disorders or depression, substance abuse disorders or other addictive behaviors are the most common mental illnesses with which the most of the population is struggling throughout the world. Behavioral health integration is an effective strategy adopted to improve the outcomes for the millions of individuals with behavioral or mental health conditions worldwide. This strategy primarily focuses on early screening and detection of mental disorder in collaboration with the primary care doctors; treatment of the metal illness in its early stage; and providing education related to substance use disorders (SUDs).

Request Report TOC: https://www.futuremarketinsights.com/toc/rep-gb-5375

SUDs primarily occurs when the recurrent use of alcohol or drugs leads to impairment such as disability, health issues, and inability to perform major activities at home, school, or work. Thus, it is one of the major contributors to the healthcare costs due to lost productivity and crime. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), it costs more than $600 billion each year to address the impact of SUDs alone in America. However, behavioral healthcare companies are working towards minimizing these costs with the adoption of new value-based medicine paradigm that prevents readmissions in hospitals through SUD and mental health treatment programs.

Behavioral Health Market: Drivers and Restraints

Rising awareness related to behavioral health issues and behavioral therapy has substantially increased the demand for behavioral health treatment thus driving the growth of the behavioral health market. The favorable supply and demand dynamics in the behavioral health market will continue to meet the rising demand for behavioral health services. Growing acceptance of treatment for mental health issues and substance of abuse and increasing political support to address the issue will drive the growth of behavioral health market. In addition to this, expanding insurance coverage with structured reimbursement environment for the treatment of behavioral health disorders. With age, the number of individuals diagnosed with behavioral health issues will increase rapidly. However, social stigma related to behavioral health issues and dearth of mental health professionals are the major factors restraining the growth of the behavioral health market.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5375

Behavioral Health Market: Overview

The behavioral health market is highly fragmented with a fewer number of large hospitals and large service providers, followed by a fragmented second tier of private players with several different business models. However, the adoption of the newly introduced Medicare value-based model of reimbursement and healthcare service will drive the consolidation in the industry. Thus, the behavioral health market will continue to consolidate among financial buyers and market leaders to strengthen their service offerings and expand geographically. American Addiction Centers, Inc. and Acadia Healthcare Company are the two most active companies in making acquisition to expand their geographical reach in the behavioral health market. Over the past two years, Acadia has completed 13 acquisitions while American Addiction Centers made six acquisitions. Here are the few examples of recent acquisitions in the industry. For instance, in November 2016, Crossroads acquired a provider of substance abuse treatment services, Starting Point, to expand its presence in South Carolina. Likewise in October 2015, Behavioral Health Group acquired two addiction treatment programs in Virginia to strengthen its footprint in the U.S.

Behavioral Health Market: Regional Outlook

Geographically, the global behavioral health market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America clearly dominates the global behavioral health market due to awareness of behavioral disorders and expansion of structured reimbursement environment in the region. The behavioral health market in Asia Pacific region is projected to witness significant growth during the forecast period.

Pre Book Behavioral Health Market Research Report: https://www.futuremarketinsights.com/checkout/5375

Behavioral Health Market: Key Players
Some of the players identified in global behavioral health market include AAC Holdings, Inc., Acadia Healthcare Company, Inc., CareTech Holdings PLC, Cambian Group plc, Centric Health Corporation, Civitas Solutions, Inc., Magellan Health, Inc., Universal Health Services, Inc., Dungarvin, Inc., Epic Health Services, Inc., Pyramid Healthcare, Inc., Hinderer Holding AG, Audax Group, Inc., Cambian Group plc, Wellspring Capital Management LLC, and MyLife Recovery Centers, Inc., among others.

India Hemostat Market to receive overwhelming hike in Revenues by 2025

In 2015, the Indian hemostat market was valued at US$ 54.1 Mn and is expected to expand at a CAGR of 5.8% over 2016–2025. This expected growth is attributed to advancements in hemostat products and increasing adoption of hemostat products by medical practitioner and surgeons, fuelled by an increase in number of surgeries and trauma cases across the country.

The Indian hemostat market is segmented on the basis of product type, product material form, application and distribution channel.

By product type, the India hemostat market is segmented into mechanical type and flowable type. Mechanical type segment includes gauzes, sponges, strips and films, and flowable type includes powder type segment. Currently, the mechanical type segment accounts for highest market share in the India hemostat market, and is expected to continue to remain the dominant type in terms of value during the forecast period as preference for this type among healthcare professional is high.
By product material form, the hemostat market is segmented into gelatin material and oxidised cellulose material segments. Gelatin material is used for manufacturing gauzes, sponges, films, strips and powder and oxidised cellulose is used in hemostat strips. Currently the gelatin material form accounts for highest market share in the India hemostat market, and this trend is expected to continue in terms of value during the forecast period. This is attributed to high preference among healthcare professionals for this type of product as it absorbs blood more quickly.

In terms of application, hemostat are used during surgeries and this segment is expected to account for over 50% of the revenue generated in the India’s hemostat market. Revenue from the trauma cases is expected to increase at the highest CAGR over the forecast period as compared to surgeries.
By distribution channel, hospital segment is expected to register an exceptional CAGR during the forecast period owing to increase in adoption rate of hemostat products and acceptance of these products by surgeons and medical practitioners. Ambulatory surgical centre segment is expected to exhibit a constant market share owing to high patient inflow at ASCs due to reimbursement for surgeries from insurance payer, which will result in decreased healthcare expenditure.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-in-1518

Summary of Table of Content:
1. Assumptions and Acronyms Used
2. Research Methodology
3. Executive Summary
4. India Hemostat Market Overview
5. India Hemostat Market Analysis, By Product
6. India Market Analysis, By Applications
7. India Hemostat Market Analysis, By Distribution Channels
8. Competition Landscape
9. Key Takeaways and Strategic Recommendations

Request to Browse Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/india-hemostat-market/toc

Europe Viscosupplementation Market to Report a CAGR of 5.1% Between 2016 and 2026

Rising prevalence of knee osteoarthritis is fuelling demand for effective treatment therapies. Hyaluronic acid-based intra-articular injections have proved to be one of the most preferred choices of treatment for symptomatic knee osteoarthritis. Hyaluronic acid-based intra-articular injections restore normal viscoelastic properties of altered synovial fluid in the knee joint, delivering effective therapeutic effect. The ultimate goal of viscosupplementation is to increase the concentration of hyaluronate in the joints so to restore the altered synovial fluid present in the joints.
The Europe viscosupplementation market has been estimated to be valued at US$ 192.0 Mn in 2015 and is expected to expand at a CAGR of 5.1% over the forecast period (2016–2026).

The Europe viscosupplementation market is segmented on the basis of product and end user.

Based on product type, the market has been segmented into single injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation. Single injection viscosupplementation product type segment is expected to exhibit the highest growth over the forecast period.
Based on end users, the market has been segmented into hospitals, ambulatory surgical centres and orthopaedic clinics. Hospitals segment currently accounts for the highest revenue share in the Europe viscosupplementation market. Orthopaedic clinics segment is also gaining prominence in Europe due to upcoming attractive reimbursement options and patient preference for single injection cycle over multiple injection cycle treatment.

Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-eu-1383

Summary of Table of Content:
1. Research Methodology
2. Assumptions and Acronyms Used
3. Executive Summary
4. Viscosupplementation Market Overview
5. Europe Viscosupplementation Market Forecast, By Product Type
6. Europe Viscosupplementation Market Forecast, By End Use
7. Europe Viscosupplementation Market Forecast, By Region
8. Western Europe Viscosupplementation Market Analysis
9. Eastern Europe Viscosupplementation Market Analysis
10. Competition Landscape

Request to BrowseTable of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/europe-viscosupplementation-market/toc

Peptide Therapeutics Market to Surge at a CAGR of 10% by 2025

In 2014, the peptide therapeutics market was valued at US$ 16,000.0 Mn and revenue is expected to expand at a CAGR of 10.3% over 2015-2025. This is attributed to advancements in the field of synthetic peptides and emergence of prominent biopharmaceutical companies, fuelled by an increase in prevalence of metabolic disorders.

The global peptide therapeutics market is segmented on the basis of application type, route of administration, drug type and region.

By application type, the global peptide therapeutics market is segmented into cancer, cardiovascular, central nervous systems, metabolic disorders, infections, hematological disorders, gastrointestinal disorders, dermatology, respiratory disorders, endocrinology and other applications. The cancer application type segment accounts for highest market share currently, and is expected to remain the leading segment in terms of value during the forecast period.

In terms of route of administration segmentation, parenteral route of administration is expected to hold more than half the global market share, while revenue from the oral route of administration segment is projected to expand at the highest CAGR over the forecast period as compared to other segments.

By drug type segmentation, generic drug type segment is expected to register an exceptional CAGR during the forecast period owing to patent expiries of large number of branded drugs.
On the basis of region, the market in North America currently holds highest share in the global market and the trend is expected to continue over the forecast period. Markets in the Americas and Europe have been estimated to collectively account for over 75% revenue share of the global peptide therapeutics market in 2015. MEA is projected to exhibit above average CAGR in terms of value between 2015 and 2025.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1038

Summary of Table of Content:

1. Research Methodology
2. Assumptions & Acronyms Used
3. Executive Summary
4. Global Peptide Therapeutics Market – Scenario Forecast
5. Global Peptide Therapeutics Market Dynamics
6. Global Peptide Therapeutics Market Analysis and Forecast By Application Type
7. Global Peptide Therapeutics Market Analysis and Forecast By Route Of Administration
8. Global Peptide Therapeutics Market Analysis and Forecast By Drug Type
9. Global Peptide Therapeutics Market Analysis and Forecast By Region
10. Company Profiles

Request to Browse Full Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/peptide-therapeutics-market/toc

Laboratory Information Systems Market to Report a CAGR of 9.0% Between 2015 and 2025

Future Market Insights (FMI) delivers key insights on the global laboratory information systems market in its latest report titled, ‘Laboratory Information Systems Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2025’. In terms of revenue, the global laboratory information systems market is projected to register a healthy CAGR of 9.0% during the forecast period (2015-2025) to account for US$ 2,745.3 Mn by 2025 end.

The global laboratory information systems market is segmented on the basis of components, delivery mode and end user.

On the basis of component, the market has been segmented into software, services and hardware. Software segment is expected to emerge as most the lucrative component segment in the global laboratory information systems market over the forecast period. The services segment is currently the most attractive segment in terms of revenue in the market, and has been estimated to account for 57.9% market share in 2015. However, market acceptance of new software products and rise in product enhancements is expected to drive rise in advent of innovative LIS systems over the forecast period.

On the basis of delivery mode, the market has been segmented into on-premises and cloud based. Cloud-based delivery mode segment is expected to emerge as the dominant segment in the global laboratory information systems market over the forecast period. The cloud based segment is currently the most attractive segment in terms of revenue in the market, and has been estimated to account for 50.8% market share in 2015. However, high and unpredictable costs of ownership of on premise delivery mode is expected to lead to decrease in revenue growth of the on premise segment during the forecast period.

On the basis of end user, the market has been segmented into hospitals, clinics, independent laboratories and others. In terms of value, the clinical segment is estimated to account for 46.8% share of the global market by 2025 end, remaining dominant and the most attractive segment throughout the forecast period.

Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-875

Summary of Table of Content:

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Global Laboratory Information Systems Market Overview
5. Global Laboratory Information Systems Market Analysis, By End User
6. Global Laboratory Information Systems Market Analysis, By Component
7. Global Laboratory Information Systems Market Analysis, By Delivery Mode
8. Global Laboratory Information Systems Market Analysis, By Region
9. North America Laboratory Information Systems Market Analysis
10. Latin America Laboratory Information Systems Market Analysis
11. Western Europe Laboratory Information Systems Market Analysis
12. Eastern Europe Laboratory Information Systems Market Analysis
13. APEJ Laboratory Information Systems Market Analysis
14. Middle East & Africa Laboratory Information Systems Market Analysis
15. Japan Laboratory Information Systems Market Analysis
16. Competition Landscape

Request to Browse Full Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/laboratory-information-systems-market/toc

Depression Drugs Market to Reflect Impressive Growth Rate During 2017 – 2027

Depression is a serious mood disorder which causes a persistent feeling of sadness and loss of interest thus affecting daily routine activities such as sleeping, walking, talking, thinking, eating etc. depression is different from temporary feeling of sadness. Signs and symptoms of depression includes persistent sadness, irritability, loss of interest in daily routine activities, feelings of worthlessness and pessimism, guilt, social withdrawal, fatigue, insomnia, loss of appetite, headache, cramps, digestive problems, weight changes, restlessness, and suicide attempts however alcoholism and drug abuse may also be the signs of depression. Signs and symptoms of depression vary from person to person depending upon the risk factors and individual thinking and lifestyle. Also there are different forms of depression which has unique character tics such as persistent depressive disorder, perinatal depression disorder, psychotic depression, Seasonal affective disorder and bipolar depression. Depression is also categorised based on its severity as mild, moderate and severe. Psychotic depression, persistent depressive disorder and bipolar disorder are the severe form of depression and should be treated with anti-depressants and psychotherapies. Depression can occur at any age but often initiates in adulthood.

Request Report TOC: https://www.futuremarketinsights.com/toc/rep-gb-3290

Depression drugs market comprises of the drugs which cures signs and symptoms caused by the depression, these drugs are known as anti-depressants. Anti-depressants includes tricyclic antidepressants, selective serotonin reuptake inhibitors, atypical antidepressants, and monoamine oxidase inhibitors. These drugs are also utilized in the treatment of a number of other mood disorders such as anxiety disorders, eating disorders, and obsessive compulsive disorder.

Depression Drugs Market: Drivers and Restraints

Depression drugs market is growing, this is attributed to increasing prevalence of depression and other mood disorders with increasing availability of various anti-depressants in the market. Factors such as increasing reliance on medications for controlling the symptoms of depression is expected to contribute significantly to the depression drugs market revenue in the near future. In addition to this, growing healthcare expenditure, and rising insurance coverage also aids the growth of depression drugs market as increasing number of relatives of depressive cases are adopting early measures to halt the deterioration process. Also, availability of newer anti-depressants drives the depression drugs market, giving enormous opportunities to the companies within this market. However side effects associated with these drugs along with availability of other treatment methods such as psychotherapy is anticipated to hamper the revenue growth of depression drugs market over the forecast period.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3290

Depression DrugsMarket: Overview

Depression drugs market is expected to grow at a significant rate, over the forecast period. The market is anticipated to perform well over the forecast period attributed to increasing number of patients suffering from mild to moderate depression along with the availability of more drugs in the market. Also the depression drugs market is expanding globally due to increasing distribution partnerships among depression drug manufactures. The Depression Drugs market is expected to grow with a fastest CAGR over the forecast period due to increasing number of pipeline antidepressants. Increasing competition among major companies in the market to develop new formulation drugs which cures more than one symptoms also drives the depression drugs market towards the growth curve.

Depression Drugs Market: Region-wise Outlook

Depending on geographic region, the depression drugs market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

Pre Book Depression Drugs Market Research Report: https://www.futuremarketinsights.com/checkout/3290

North America is the largest regional market owing to high patient awareness levels regarding availability of various drugs for depression, rising healthcare expenditure and relatively larger number of R&D exercises pertaining to drug manufacturing and marketing etc. these factors contribute for significant revenue generation from the region.
Asia Pacific excluding Japan is expected to grow at the fastest CAGR because of increasing prevalence of depression and mood disorders in the region along with more focus of the companies to target the markets such as India and China leads to increase in the revenue growth of depression drugs market throughout the forecast period.
Depression Drugs Market: Key Players
Some of the players in depression drugs marketinclude AstraZeneca, GlaxoSmithKline, Merck & Co., SK Biopharmaceuticals, Novartis, Forest Laboratories, Naurex etc. whereas some and regionalplayers also have a significant presence in depression drugs market.

Wound Irrigation Devices Market to Reflect Impressive Growth Rate During 2017 – 2027

The wound irrigation system is a flow of the solution used to an open wound surface to achieve the hydration of wound, to remove the debris and help in the visual examination of the wound. Wound irrigation is an important step in assisting the progression of wound healing from inflammatory phase to proliferative phase by removing the debris and surface pathogens. The goal of the wound irrigation is to clean the wound and avoid the trauma to wound bed to minimize the risk of bacterial and other contamination to the wound bed. Wound irrigation system also aids in healing the wound from the inside tissue layers outward to the surface of the skin and prevent premature healing of the wound. In wound irrigation system, the irrigation solutions such as topical cleansers, antibiotics, antifungal, antiseptics are used to remove the debris. The wound irrigation system is more effective as compared to swabbing or bathing of the wound and expected to boost the demand of the wound irrigation system over a forecast period.

Request Report TOC: https://www.futuremarketinsights.com/toc/rep-gb-3775

The global wound irrigation system market is anticipated to register a significant CAGR over a forecast period. The increasing use of convenient, user-friendly wound irrigation system over conventional wound cleaning techniques such as swabbing and bathing, is expected to boost the demand of the wound irrigation system and drives the global market. The wound irrigation system is more effective as it delivers the major advantage in emergency room acute wound management which also propels the demand of the wound irrigation system. The wound irrigation system also helps to prevent the spread of infection of bacteria and other pathogens due to the effective structure of the system, which anticipated to fuel the demand and growth of the global wound irrigation system market over a forecast period.

However, the lack of awareness about the benefits of the wound irrigation system over conventional methods of wound cleaning in poorly developed markets, may hamper the demand of the wound irrigation systems and restrain the growth of the global wound irrigation system market.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3775

On the basis of regional presence, the global wound irrigation system market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. Currently, North America is contributing the leading shares to the global wound irrigation system market in terms of value and anticipated to register a significant CAGR over a forecast period. The Europe is also contributing the moderate shares to the market due to the advanced medical facilities and developed infrastructure along with the awareness of the wound irrigation system over conventional methods. APAC is the most lucrative market for the wound irrigation system and expected to show a robust growth to the global wound irrigation system market. MEA is at a nascent stage to the global wound irrigation system market and anticipated to register a decent growth to the market over a forecast period. Overall, the global wound irrigation system market is expected to show significant growth over a forecast period.

Some of the major market players in wound irrigation system market globally include Bionix Development Corporation, Molnlycke Health Care Ltd, Teleflex, Inc., IrriMax Corporation, Westmed, INC., CooperSurgical Inc., B. Braun Medical Inc., Centurion Medical Products Corporation and Zimmer, Inc.

Pre Book Wound Irrigation System Market Research Report: https://www.futuremarketinsights.com/checkout/3775

Western Blotting Market to Surge at a CAGR of 5.4% by 2021

Future Market Insights examines the global western blotting market for a five-year forecast period 2016-2021. FMI indicates that the market will see steady growth over the aforementioned period. The revenues are expected to reach US$ 551.0 Mn by the end of 2016 and the market may expand at a CAGR of 5.4% during 2016-2021.

The global western blotting market is segmented on the basis of type, end-use, and region.

By product, the global market for western blotting is segmented into electrophoresis blotting systems, reagents kits, and transfer membranes. The reagents kits segment is expected to retain dominance over the forecast period; however FMI indicates a declining growth rate for this segment post-2016. This segment will account for nearly US$ 426.4 Mn by 2021 end, capturing over 58% share of the market. It is further segmented into chromogenic, chemiluminescent, antibodies, fluorescent, and buffer. The electrophoresis blotting systems segment is likely to exhibit substantial growth at a CAGR of 7.4%, reaching a value of around US$ 222.9 Mn by 2021 end.

Based on end-use, the market is segmented into diagnostic laboratories, research institutions, and pharmaceutical and biotech companies. Among these, pharmaceutical and biotech companies segment will continue to lead with the maximum revenue share by 2021 end. However, research institutions segment is expected to thrive at a higher CAGR during the forecast period, followed by diagnostic laboratories segment with the least market share.

By geographical analysis, the global western blotting market is segmented into five key regional markets. North America is projected to continue dominance in 2016 through to 2021, primarily attributed to rising incidences of AIDS and Lyme disease, increased GMO crops production, and promising clinical research efforts. This region is also witnessing soaring research funds, in addition to an initiative for HIV vaccine development. While these factors are likely to drive the western blotting market in North America, the revenues of this region may reach US$ 253.8 Mn by 2021 end, accounting for over 35% share of the entire market value in 2021.

Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1050

Summary of Table of Content:
1. Research Methodology
2. Assumptions & Acronyms Used
3. Executive Summary
4. Global Western Blotting Market Overview
5. Global Western Blotting Market Analysis and Forecast By Product
6. Global Western Blotting Market Analysis and Forecast By Application
7. Global Western Blotting Market Analysis and Forecast By End Use
8. Global Western Blotting Market Analysis and Forecast By Region
9. Global Western Blotting Market: Competitive Landscape
10. Strategic Recommendations

Request to Browse Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/western-blotting-market/toc

Halal Nutraceuticals & Vaccines Market to Surge at a CAGR of 7.7% by 2026

According to research report compiled by Future Market Insights, the global halal nutraceuticals & vaccines market, which is currently valued at US$ 39,265 million, is projected to expand at a 7.7% CAGR and reach US$ 82,207 million over the forecast period, 2016-2026.

The global halal nutraceuticals & vaccines market is segmented on the basis of products, distribution channel, applications and region.

Japan is anticipated to be the smallest market for halal products, growing at a CAGR of 4.7%. In Japan, halal vaccines are expected to be launched in the year 2022 and the market is forecasted to cross US$ 0.1 Mn by 2022 end and is expected to be valued more than US$ 0.3 Mn by 2026 end.
Halal dietary supplements product type segment is estimated to be valued above US$ 110 Mn by 2026 end, expanding at a CAGR of 4.5% during the forecast period.
Hospital pharmacies is the largest distribution channel segment in terms of revenue share in Japan and is expected to account for more than US$ 45 Mn by 2026.
Supermarkets segment is anticipated to hold 10.71% market share by 2026. Retail pharmacies segment is expected to grow at the lowest CAGR of 3.8% owing to the more preferred conventional distribution methods such as hospital pharmacies.

Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2703

Summary of Table of Content:

1. Executive Summary
2. Market Overview
3. Global Halal Nutraceuticals & Vaccines Market Dynamics
4. Global Halal Nutraceuticals & Vaccines Market Forecast
5. Global Halal Nutraceuticals & Vaccines Market Forecast, By Product
6. Global Halal Nutraceuticals & Vaccines Market Forecast, By Distribution Channel
7. Global Halal Nutraceuticals & Vaccines Market Forecast, By Applications
8. Global Halal Nutraceuticals & Vaccines Market Forecast, By Region
9. North America Halal Nutraceuticals & Vaccines Market Forecast
10. Latin America Halal Nutraceuticals & Vaccines Market Forecast
11. Western Europe Halal Nutraceuticals & Vaccines Market Forecast
12. Eastern Europe Halal Nutraceuticals & Vaccines Market Forecast
13. APEJ Halal Nutraceuticals & Vaccines Market Forecast
14. Japan Halal Nutraceuticals & Vaccines Market Forecast
15. MEA Halal Nutraceuticals & Vaccines Market Forecast
16. Major Halal Certifying Agencies, By Region
17. Competitive Landscape
18. Research Methodology
19. Assumptions & Acronyms

Request to Browse Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/halal-nutraceuticals-and-vaccines-market/toc

Microfluidics Market to Surge at a CAGR of 14.4% by 2026

Applications of microfluidics in drug delivery and diagnostics will continue to fuel the market for microfluidics over the next few years. “The US$ 2.9 Bn microfluidics market will possibly cross US$ 11 Bn by the end of 2026. North America is expected to contribute over US$ 3 Bn to the total revenues in 2026. The collective share of North America and Asia Pacific will be over 40%,” states Future Market Insights in a recently published market report outlook, titled “Microfluidics Market: Global Industry Analysis and Opportunity Assessment, 2016-2026.”

The global microfluidics market is segmented on the basis of material type, application, industry and region.

Based on material, ceramics will continue to be the most sought after material for microfluidic device or kit manufacturing. Ceramics segment is expected to remain dominance, accounting for over 42% market value share in 2026, followed by glass, polymer, and silicon. While ceramics is likely to witness the fastest growth, polymer segment is anticipated to exhibit a significant CAGR of over 15% over 2016-2026, driven by PVC.

By application, POCT (point of care testing) segment is projected to retain dominance through 2026, accounting for over 33% share in terms of revenues. Clinical diagnostics and analytical testing will remain the next major segments in the global microfluidics market.

On the basis of industry, in-vitro diagnostics, life science research, and pharmaceuticals are likely to be the key segments. In-vitro diagnostics segment is estimated to hold a share of over 35% in the total market revenues. The fastest growing segment will be in-vitro diagnosis.

Geographically, North America, followed by Western Europe are expected to remain the dominant regions for microfluidics, capturing respective market value share of over 26% and over 21% share by 2026 end. Asia Pacific (excluding Japan) will possibly represent the most lucrative market, expanding at a significant CAGR of over 14% throughout the forecast period.

Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-398

Summary of Table of Content:

1.Executive summary
2.Research Methodology
3.Assumptions and Acronyms Used
4.Global Microfluidics Market Overview
5.Global Microfluidics Market Dynamics
6.Global Microfluidics Market Trends
7.Global Microfluidics Market– Scenario Forecast
8.Global Microfluidics Market Value Chain Analysis
9.Global Microfluidics Market Price Projections per Region
10.Global Microfluidics Market Analysis by Material Type
11.Global Microfluidics Market Analysis by Application Type
12.Global Microfluidics Market Analysis by Industry
13.Global Microfluidics Market Analysis by Geography
14.North America Target Market Analysis and Forecast
15.Latin America Target Market Analysis and Forecast
16.Western Europe Market Analysis and Forecast
17.Eastern Europe Market Analysis and Forecast
18.APEJ Market Analysis and Forecast
19.Japan Market Analysis and Forecast
20.MEA Market Analysis and Forecast
21.Global Microfluidics Market: Competitive Landscape

Request to Browse Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/microfluidics-market/toc

Urinary Tract Infection Treatment Market Will be Worth US$ 11.58 Bn by 2026

The global Urinary tract infection treatment market was valued at US$ 9.2 Bn in 2015, and is projected to expand at a CAGR of 2.1% over forecast period 2016–2026, owing to increasing incidence of UTIs and recurring UTIs, increasing use of urinary catheters, and other drainage devices.

The global urinary tract infection treatment market is segmented on the basis of drug type, indication, distribution channel and region.

The global urinary tract infection treatment market is segmented into penicillin & combinations, quinolones, cephalosporin, aminoglycoside antibiotics, sulphonamides, azoles and amphotericin B, tetracycline, nitrofurans, and other segments.

By indication, the global urinary tract infection treatment market is segmented into complicated urinary tract infection, recurring complicated urinary tract infection, uncomplicated urinary tract infection, and neurogenic bladder infection. The neurogenic bladder infections indication segment is expected to expand at a CAGR of 2.6% in terms of revenue over the forecast period.
By distribution channel, the global urinary tract infection treatment market is segmented into hospital pharmacies, gynecology and urology clinics, drug store, retail pharmacies, and online drug stores. The online drug stores distribution channel segment is expected to expand at a CAGR of 2.8% in terms of revenues over the forecast period.

The global urinary tract infection treatment market has been segmented into seven major regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Japan and Middle East & Africa (MEA). Revenue from the North America market is expected to expand at a CAGR of 2.0% over the forecast period. In North America, the quinolones segment is expected to register a CAGR of 2.6% to reach value of US$ 695.4 Mn by 2026 end.

Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1340

Summary of Table of Content:
1.Assumptions and Acronyms Used
2.Research Methodology
3.Executive Summary
4.Urinary Tract Infection Treatment Market Overview
5.Global Urinary Tract Infection Treatment Market Analysis, By Drug Type
6.Global Urinary Tract Infection Treatment Market Analysis, By Distribution Channel
7.Global Urinary Tract Infection Treatment Market Analysis, By Indication
8.Global Urinary Tract Infection Treatment Market Analysis, By Region
9.North America Urinary Tract Infection Treatment Market Analysis
10. Latin America Urinary Tract Infection Treatment Market Analysis
11. Western Europe Urinary Tract Infection Treatment Market Analysis
12. Eastern Europe Urinary Tract Infection Treatment Market Analysis
14. Japan Urinary Tract Infection Treatment Market Analysis
15. MEA Urinary Tract Infection Treatment Market Analysis
16. Competition Landscape

Request to Browse Full Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/urinary-tract-infections-market/toc

Companion Animal Vaccines Market Will be Worth US$ 4,500 Mn by 2026

The global companion animal vaccines market was valued at more than US$ 2,100 Mn in 2015 and is projected to register a CAGR of 6.8% during the forecast period. The market is expected to be valued at nearly US$ 4,500 Mn by the end of 2026.

The Global Companion Animal Vaccines Market is segmented on the basis of species type, product type, distribution channel and region.

The Canine species segment is anticipated to register a 6.9% CAGR over the forecast period and be valued at nearly US$ 2,500 Mn by 2026 end.
Attenuated Live Vaccines will Continue to Witness Highest Demand. Nearly US$ 764 Mn worth of attenuated live vaccines were sold globally in 2016. This segment is projected to grow at a CAGR of 7.3% during the forecast period 2016-2026.
In 2016, these two distribution channels collectively accounted for nearly 75% revenue share of the market. By the end of forecast period, the status quo is expected to remain unchanged. Retail pharmacies, which held 20% share of the market in 2016, will grow at the highest CAGR during the forecast period.
The North America companion animals market was valued at nearly US$ 676 in 2016. It is projected to increase at 6.9% CAGR through 2026, reaching over US$ 1.3 Bn in revenues. Western Europe, the second-largest market for companion animal vaccines is projected to grow at 7.1% CAGR through 2026.

Request A Sample Request: https://www.futuremarketinsights.com/reports/sample/rep-gb-1427

Summary of Table of Content
1. Executive Summary
2. Market Introduction
3. Companion Animal Vaccines Market Analysis Scenario
4. Companion Animal Vaccines Market Dynamics
5. Global Companion Animal Vaccines Market Analysis and Forecast, By Product Type
6. Global Companion Animal Vaccines Market Analysis and Forecast, By Distribution Channel
7. Global Companion Animal Vaccines Market Analysis and Forecast, By Species Type
8. Global Companion Animal Vaccines Market Analysis and Forecast, By Region
9. North America Companion Animal Vaccines Market Analysis and Forecast
10. Latin America Companion Animal Vaccines Market Analysis and Forecast
11. Western Europe Companion Animal Vaccines Market Analysis and Forecast
12. Eastern Europe Companion Animal Vaccines Market Analysis and Forecast
13. Asia Pacific Excl. Japan (APEJ) Companion Animal Vaccines Market Analysis and Forecast
14. Japan Companion Animal Vaccines Market Analysis and Forecast
15. MEA Companion Animal Vaccines Market Analysis and Forecast
16. Competition Landscape
17. Assumptions and Acronyms Used
18. Research Methodology

Request to Browse Full Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/companion-animal-vaccines-market/toc

Outpatient Clinics Market to Report a CAGR of 4.3% Between 2017 and 2027

Growing advancements in medical technology has led to development of treatment techniques and medications that do not require the patients to stay for long hours at the clinics or hospitals. However, imposition of strict regulations will continue to hinder the global market growth of outpatient disorders over the forecast period. Future Market Insights states that the global market of outpatient clinics is projected to reflect a CAGR of 4.3%, representing more than US$ 39,000 Mn by 2022-end.

Read Report Preview: https://www.futuremarketinsights.com/reports/outpatient-clinics-market

Factors Fuelling Global Market Growth

Growth of the global outpatient clinics market is mainly bound to various macro-economic and micro-economic factors. Prevalence of chronic diseases such as asthma, diabetes, depression and congestive heart failures lead to complex and severe health problems. With the escalating cost of treatment process in various healthcare organizations, patients prefer visiting the outpatient clinics for accessing treatment. Growing concerns regarding the increasing prevalence of cardiovascular diseases such as elevated blood pressure levels, hypertension, coronary heart diseases and cerebrovascular diseases has further led to surge in demand for the outpatient clinics globally.
Demand for quick and effective treatment of cardiovascular diseases will continue to contribute towards the global market growth of outpatient disorders. According to a recently published report by CDC, nearly 610,000 people die of heart attack in the U.S. each year, which is 1 in every 4 deaths. As cardiovascular diseases continue to remain a leading cause of mortality globally, demand for effective and quick treatment process will continue to remain high. These factors are projected to impact the global market growth of outpatient clinics throughout the forecast period.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5697

Collaborations among the private insurance companies and outpatient clinics will continue to remain a major trend in the global market. Through collaborations the private insurance companies offer payment and services in outpatient clinics. Imposition of regulations such as Health Care and Educational Reconciliation Act and Patient Care Affordable Act provides the U.S. citizens with the public health insurance coverage and offers access to private health insurance services. Moreover, increasing employee benefits such as Employees’ health insurance by the employers is projected to contribute towards the global market growth of outpatient clinics over the forecast period.
However, the global market of outpatient clinics will continue to witness inhibiting growth attributed to various factors. Imposition of strict regulations and limited number of doctors for the treatment of various diseases will remain a key factor inhibiting demand for services offered by outpatient clinics. As the patients are not monitored for a long period of time, risk of addiction to alcohol and drugs is projected to remain high. Moreover, lack of access to counselors in comparison to the residential and inpatient facility is further projected to impede the global market growth of outpatient clinics.

Buy Outpatient Clinics Market Research Report: https://www.futuremarketinsights.com/checkout/5697

Sales to Remain High Through Cardiology Specialty Areas

Prevalence of chronic and cardiovascular disorders is projected to fuel demand for the multi-specialty centers globally. In terms of revenue, the multi-specialty center type segment is projected to witness significant growth, representing more than US$ 8,400 Mn by 2022-end. Moreover, the multi-specialty center type segment is projected to reflect the fastest growth in the global market of outpatient clinics throughout the forecast period.

On the basis of specialty type, the dermatology segment is projected to reflect a significant CAGR through 2022. However, the cardiology specialty areas segment is projected to represent a robust revenue growth, recording more than US$ 3,000 Mn over the forecast period.

Market Players

Major players in the global market of outpatient clinics are Kaiser Permanente Inc., M D Anderson Cancer Center, Mayo Clinic, Memorial Sloan Kettering, University of Maryland Medical Center, DaVita Inc., Cleveland Clinic, Fresenius Medical Care and Johns Hopkins Medicine.

Sleep Apnea Diagnostic System Market to Become Worth more than US$ 600 Mn by 2026

Future Market Insights delivers key insights on the global sleep apnea diagnostic system market in its upcoming report titled “Sleep Apnea Diagnostic System Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” The global sleep apnea diagnostic system market is estimated to exhibit a 7.3% CAGR by value during the assessed period, owing to numerous factors, about which Future Market Insights offers thorough insights and forecasts in this report.
Under the polysomnography devices, ambulatory PSG monitoring devices and clinical PSG monitoring devices are the two sub-segments that contribute to the polysomnography (PSG) devices. To provide in-depth insights on the pattern of demand defining the global sleep apnea diagnostic system market, the market is segmented into different types of end users. The home care settings segment is likely to witness a significant CAGR of 8.0% in the next 10 years in value terms. The actigraphy monitoring device product type segment is estimated to register a significant value CAGR of more than 8% during the forecast period.

Read Report Preview: https://www.futuremarketinsights.com/reports/sleep-apnea-diagnostic-system-market

The factors powering demand for sleep apnea diagnostic systems are increasing healthcare expenditure on home care testing equipment and wearable devices. Increasing prevalence of obstructive sleep apnea is likely to lead to significant growth in cost incurred for treatment of sleep apnea, which is anticipated to create demand for more advanced devices for diagnosis of sleep apnea. Reimbursement companies adopt a more favorable policy towards HST over in-lab testing. Thus, rising demand for equipment and wearable devices used in HST testing is in turn expected to drive global sleep apnea diagnostic system market growth. Chronic snoring is a strong indicator of sleep apnea. Factors that can affect sleep quality include sleep biology, circadian rhythm, and shift work. Sleep can also be disturbed due to tension, depression and fatigue. These factors in turn are expected to positively impact the sleep apnea diagnostic system market during the projected period.
However, most patients suffering from sleep apnea do not know the difference between general sleeping disorders and normal snoring problems. Moreover, most patients are inclined towards symptomatic treatment. This is projected to inhibit the global sleep apnea diagnostic system market growth in the next few years.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-777

Segmentation analysis

• Portable monitoring is used as an alternative test for obstructive sleep apnea as it is less expensive on account of its portability and requires less space. Also, it is quicker to initiate the process as compared to in-laboratory polysomnography testing. Owing to its usability as a device for ambulatory testing, the polysomnography segment is likely to witness moderate growth in the coming years.
• The home care settings segment is projected to witness robust growth due to better patient compliance as compared to the in-labs testing segment.

Regional analysis

Due to high obesity rates and improper lifestyles, the adoptability of sleep apnea services are higher in the North America region. Introduction of updated devices and owing to the simple and easy process of their regulatory approval, the market in North America is creating a positive impact on the global sleep apnea diagnostic system market.

Buy Sleep Apnea Diagnostic System Market Research Report: https://www.futuremarketinsights.com/checkout/777

This report assesses trends driving the growth of each segment of the global as well as regional markets and offers potential takeaways that could prove substantially useful to sleep apnea diagnostic system manufacturers looking to enter the global sleep apnea diagnostic system market. The North America market has been estimated to dominate the global sleep apnea diagnostic system market, accounting for maximum revenue share of the market by 2016 end. Collectively, North America and Western Europe markets are expected to account for approximately 66% revenue share of global sleep apnea diagnostic system market by 2016 end. Western Europe is projected to exhibit a significant CAGR of 7.4% between 2016 and 2026, followed by the Japan sleep apnea diagnostic systems market.

Vendor insights

Some of the leading companies operating in the global sleep apnea diagnostic system market include SOMNOmedics GmbH, Dickinson and Company, Braebon Medical Corporation, Advanced Brain Monitoring, Inc., Becton, Natus Medical Incorporated, MGC Diagnostics Corporation, Cleveland Medical Devices Inc., Koninklijke Philips N.V.,BMC Medical Co, Ltd., and ResMed Inc.

3D Printed Medical Devices Market to Become Worth US$ 1469.4 million by 2026

Future Market Insights delivers key insights on the global 3D printed medical devices market in a new publication titled “3D Printed Medical Devices Market: Global Industry Analysis and Opportunity Assessment, 2016 – 2026”. The global 3D printed medical devices market was estimated to be US$ 238 Mn in 2015 and it has a wide scope of growth in the forecast period. The global 3D printed medical devices market can be broadly classified into six segments depending on the technology namely – stereolithography (SLA), selective layer sintering (SLS), digital light processing (DLP), fused deposition modelling (FDM), polyjet / inkjet 3D printing, and electronic beam melting (EBM) – each with different applications that are specific to orthopaedic, dental, and internal and external prosthetics. The global 3D printed medical devices market is expected to reach US$ 279.6 Mn in 2016, witnessing a year-on-year growth of 17.5%.

Read Report Preview: https://www.futuremarketinsights.com/reports/3d-Printed-medical-devices-market

According to Future Market Insights analysts, factors such as a rising prevalence of disorders such as diabetes-related gangrene cases, peripheral vascular diseases, and osteoarthritis among elderly individuals are leading to the use of 3D printed medical devices. Some of the other factors are cases where dental implants and cranio-maxillofacial implants are required. These factors are collectively anticipated to fuel the revenue growth of the global 3D printed medical devices market over the forecast period. In addition, factors such as rising awareness regarding personal care, increasing prevalence of chronic diseases, increase in incidence of accidents, and increasing geriatric population are anticipated to enhance the growth of the global 3D printed medical devices market over the forecast period.

However, only a few selected materials such as resins, plastics and a few metals are used for 3D printing. Usage of other materials for 3D printing results in high operational costs and is time consuming. Also, size of the printer limits the size of the product and thus, it is a challenging job to produce parts of large industrial machines. Moreover, a key limiting factor in the adoption of 3D printing are technical barriers. These are complex equipment and so most of the 3D printing manufacturers are utilising open source technology. As adjusting equipment and printing parameters are time consuming processes, users lose interest in learning or knowing to operate such devices.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1501

Segmentation highlights

By technology, the SLS technology segment accounted for a higher revenue share in the global 3D printed medical devices market in 2015 as compared to other product segments. The SLS technology segment is expected to reach a value of US$ 230.0 Mn by 2026, registering a CAGR of 15.3% over the forecast period. Though the value of the polyjet / inkjet 3D printed medical devices technology segment was lower as compared to the SLS technology segment in 2015, due to a growing demand and increasing applications, its value over the forecast period is expected to be the highest amongst the other categories in the technology segment.

By material, the plastics material segment accounted for a higher revenue share in the global 3D printed medical devices market as compared to others. The plastic material segment is expected to reach a value of US$ 984.7 Mn by 2026, registering a CAGR of 17.2% over the forecast period.
By application, the orthopaedic implants application segment accounted for a higher revenue share in the global 3D printed medical devices market as compared to other segments. The orthopaedic implants application segment is expected to reach a value of US$ 643.5 Mn by 2026, reflecting a CAGR of 19.9% over the forecast period.

Buy 3D Printed Medical Devices Market Research Report: https://www.futuremarketinsights.com/checkout/1501

By distribution channel, the hospitals end user segment accounts for higher demand for 3D printed medical devices as compared to other distribution channel segments such as ambulatory surgical centres and diagnostic centres, registering a CAGR of 18.7% over the forecast period.

Regional market projections

Sales of 3D printed medical devices are relatively healthy in the U.S. market in recent years, making North America the most lucrative market globally. The North America 3D printed medical devices market revenue was accounted to be US$ 105.0 Mn in 2015, with the U.S. accounting for a majority of revenue share. In addition to North America, 3D printed medical devices sales are expected to grow gradually in Western Europe, Eastern Europe, and APEJ. Revenues in Western Europe are expected to register a CAGR of 18.5%, whereas Eastern Europe is anticipated to register a CAGR of 15.6% over the forecast period.

Vendor insights

Key players in the global 3D printed medical devices market include 3D Systems, Inc., Arcam AB, Stratasys Ltd., FabRx Ltd., EOS GmbH Electro Optical Systems, EnvisionTEC, Cyfuse Biomedical K.K., and Bio3D Technologies. Major market players are implementing different strategies and are launching new products in order to grow their market share.

Teleradiology Services Market to Become Worth US$ 1,971.4 Mn by 2026

Future Market Insights delivers key insights on the global teleradiology services market in a new publication titled “Teleradiology Services Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”. Teleradiology is the practice of interpretation and analysis of medical images by a radiologist who is not present at the site where the images are generated. This service is utilised by hospitals, emergency care centres, telemedicine companies, and other clinics. Teleradiology services enable radiologists to use online services in order to improve patient care and treatment without the need to be physically present on site. In terms of revenue, the global teleradiology services market is projected to register a healthy CAGR of 21.0% over the forecast period (2016 – 2026) and increase 6.7x in terms of revenue between 2016 and 2026.

Read Report Preview: https://www.futuremarketinsights.com/reports/teleradiology-services-market

The global teleradiology services market is anticipated to project exponential growth over the next 10 years owing to increasing incidences of chronic diseases such as cancer, tumours, and orthopaedic diseases; increasing geriatric population; and excessive hospitalisations and increasing admittance in ambulatory surgical centres and clinics. Increasing consumer awareness regarding teleradiology and easy accessibility to the technology is another key factor likely to drive the global demand for teleradiology services. However, high cost of technology and services, image transmission issues, dearth of trained radiologists and technicians, and a low awareness in emerging economies is likely to pose major challenges for the growth of the global teleradiology services market. Ongoing trends for teleradiology services driving the global market include service offerings with the latest IT infrastructure including artificial intelligence and algorithms, cloud with low maintenance, and image backup storage.

Segmentation highlights

The global teleradiology services market is segmented on the basis of Process Type (Certified Reporting Services Process, Preliminary Reporting); Service Type (Emergency Nighthawk, Day Time Coverage, Subspecialty Reading, Second Opinion, Clinical Trails); Modality (X-Ray Scans, Computerised Tomography (CT) Scans, MRI Scans, Ultrasound Scans, Nuclear Scans, Cardiac Echo, Mammography, Electromammography); and End User (Hospital Pharmacies, Clinics, Ambulatory Surgical Centres, Radiology Centres).

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2100

Certified Reporting Services Process segment is estimated to account for 62.9% revenue share of the global teleradiology services market by 2016 end

Emergency Nighthawk service type segment accounted for 31.6% value share in 2015 and is anticipated to dominate the global teleradiology services market throughout the forecast period
Computerised Tomography (CT) Scans modality segment is anticipated to register a CAGR of 23.6% between 2016 and 2026

Hospital Pharmacies end user segment is estimated to account for 39.9% revenue share of the global teleradiology services market by 2016 end

Regional market projections

The global teleradiology services market is segmented on the basis of region into U.S. and OUS (International) (Latin America, EU5, Rest of Europe, Japan, Asia Pacific Excluding Japan, Rest of the World). The U.S. regional market dominated the global teleradiology services market in revenue terms in 2015 and is projected to account for 41.2% market value share by 2026 end. The EU5 region is expected to be the second most lucrative segment in the global teleradiology services market with a market attractiveness index of 1.3 during the forecast period.

Buy Teleradiology Services Market Research Report: https://www.futuremarketinsights.com/checkout/2100

Vendor insights

The report profiles some of the leading players operating in the global teleradiology services market. Top companies featured in the report include Teleradiology Solutions, Argus Radiology, SRL Diagnostics, USARAD Holdings Inc., Vital Radiology Services, Teleradiology Providers, Telemedicine Clinic, TeleDiagnosys Services Pvt. Ltd, Imaging Advantage, Foundation Radiology Group, Direct Radiology, Imaging On Call LLC, ONRAD Inc., Rays (Envision Healthcare Company), StatRad LLC, ARIS Radiology, NightShift Radiology, Mednax Inc., Alta Vista TeleRadiology, and Quality Nighthawk. These established players are focussed on strategic moves such as new product launches, increasing their distribution channels, and getting into partnerships and agreements with hospitals and specialty clinics to increase the brand awareness of their product.

Ophthalmic Lasers Market is Expanding at a CAGR of 4.8% by 2026

Future Market Insights provides a detailed analysis of the global ophthalmic lasers market in a new report titled “Ophthalmic Lasers Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”. The global ophthalmic lasers market was valued at US$ 421.5 Mn in 2015 and is estimated to reach US$ 437.2 Mn by 2016 end, with a Y-o-Y growth rate of 3.7%.

Market dynamics

Factors such as rising prevalence of ophthalmic diseases leading to laser ophthalmic procedures and a growing elderly population susceptible to ophthalmic diseases such as cataract and glaucoma is anticipated to fuel the revenue growth of the global ophthalmic lasers market over the forecast period. Factors such as growing ophthalmic care expenditure, rising government provision in developed economies, constructive reimbursement policies, and increasing disposable income per capita are anticipated to enhance the growth of the global ophthalmic lasers market over the forecast period. However, high costs associated with ophthalmic lasers and replacement of current ophthalmic laser technology with advanced technologies might hinder the growth of the global ophthalmic lasers market over the forecast period.

View Report Preview: https://www.futuremarketinsights.com/reports/ophthalmic-lasers-therapeutic-market

Segmentation highlights

The global ophthalmic lasers market is segmented on the basis of Product Type (Photo-coagulation Lasers, Photo-disruption Lasers, Selective Laser Trabeculoplasty); Disease Type (Diabetic Retinopathy, Glaucoma Surgery, Cataract Surgery, Others); and End User (Hospitals, Ambulatory Surgical Centres, Ophthalmic Clinics).

• The Selective Laser Trabeculoplasty product type segment is estimated to reflect a Y-o-Y growth rate of 4.3%. The Photo-coagulation Lasers segment is anticipated to register a CAGR of 4.6% over the forecast period.
• The Glaucoma Surgery disease type segment is estimated to account for the highest market revenue share of the global ophthalmic lasers market by 2016 end. The Diabetic Retinopathy segment is estimated to account for the second highest market share of the global ophthalmic lasers market by 2016.
• The Ophthalmic Clinics end user segment is anticipated to account for the highest market share of 45.1% of the global ophthalmic lasers market by 2016 end and register a CAGR of 5.6% over the forecast period. The Ambulatory Surgical Centres segment is estimated to reflect a Y-o-Y growth of 3.9% in 2016 over 2015.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1529

Regional forecast

The global ophthalmic lasers market is segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and MEA. North America is expected to dominate the global ophthalmic lasers market in terms of revenue and is estimated to be valued at US$ 242.4 Mn by the end of 2026. North America is anticipated to account for the highest market share of 31.8% of the global ophthalmic lasers market by the end of 2016 while Western Europe is estimated to hold the second highest market share of 33.9% of the global ophthalmic lasers market by the end of 2016. The North America, Western Europe, and APEJ markets represent the highest growth opportunities in the global ophthalmic lasers market owing to a large patient population and more demand for laser technologies in diabetic retinopathy and glaucoma surgeries.

Vendor insights

The global ophthalmic lasers market report profiles some of the top companies operating in the global ophthalmic lasers market. Leading market players featured in the report are Ellex Medical PTY Ltd., Lumenis Ltd., IRIDEX Corporation, ZEISS International, NIDEK CO. LTD., Novartis AG, Topcon Corporation, and Quantel SA. These companies are focussing on developing new technologies to aid in seamless ophthalmic surgeries and are looking to penetrate new and emerging markets through strategic acquisitions.

Biopsy Device Market Will be Worth US$ 2,700 Mn by 2026

Key players focussing on strategic M&A for amplified market shares

Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and biopsy device thereby.

Over the 10-year forecast period 2016-2026, the global biopsy device market is estimated to witness a moderate yet promising CAGR of 6.5%, according to Future Market Insights. In a recently published report titled “Global Biopsy Device Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”, Future Market Insights analyses the market for biopsy device and offers key insights into the market condition for the aforementioned period. Valued at around US$ 1,397 Mn in 2016, the market will possibly attain the revenues beyond US$ 2,621 Mn by 2026-end.

View Report Preview: https://www.futuremarketinsights.com/reports/biopsy-device-market

Key Opportunities for Manufacturers and Suppliers, Grasped by Future Market Insights Research:

• Developing economies present lucrative, untapped markets for biopsy device.
• Growing adoption of hybrid imaging technology will underpin new growth opportunities.
• Following massive consumption by hospitals, demand for biopsy device from specific oncology centres and research institutes will prompt at multiple opportunities in near future.
• Surging demand for minimal invasive breast biopsy highlight lucrative opportunities that lie in the breast cancer sector.
• Increasing adoption of biopsy device by oncologists will generate several revenue generation opportunities in the disease monitoring sector.

Supported by increasing discretionary funding for cancer research, growing government expenditure for healthcare and favourable reimbursement scenario (especially in the U.S.) will collectively elevate the revenue sales of the global biopsy device market. Collaborations between various government and private companies, fuelled by increasing awareness about disease diagnosis and monitoring, will further elevate the market growth in near future.

M&A and Technological Upgrades Remain at the Forefront

A majority of key players in the global biopsy device market are currently focusing on providing innovative biopsy tests and technological upgrades. Mergers, acquisitions, and partnerships with diagnostic laboratories will help to strengthen their presence in the global market.
Among the top companies, Becton, Dickinson and Company is concentrating on innovative, cost-effective product development, whereas Hologic, Inc. is targeting manufacture and sales of biopsy devices, especially for breast cancer surgeries. Other notable players include Boston Scientific Inc., C. R. Bard, Inc., B. Braun Melsungen AG, Cook Medical, INRAD Inc., and PLANMED OY.
Argon Medical, one of the promising new entrants, is expanding its product portfolio and collaborating with established players, whereas for Devicor Medical Products Inc., M&A remains the key strategy.

North America Retains the Most Lucrative Market, Developing Countries to Witness Impressive Growth over 2016-2026

North America will remain the dominant market, reaching nearly US$ 882 Mn by 2026 end, accounting for over 33% share of the market. Western Europe is expected to remain the second largest market for biopsy device, crossing a value of US$ 683 Mn by the end of 2026, capturing over 26% share of the market.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1192

APEJ, with around 14% market value share in 2026, is likely to reach US$ 370.0 Mn by the end of forecast period. MEA will register the fastest CAGR of 7.3%, followed by APEJ and Latin America with the respective CAGRs of 7.1% and 6.5% over 2016-2026. North America, Europe, and Japan will see moderate growth over the forecast period.

Needles Continue to Drive Product Type Segment

By product type, needles will remain dominant with over 36% share of the market value in 2026, whereas guns will represent the second largest sub-segment with over 26% market value share in 2026. With growing significance of early diagnosis of breast biopsy, guidance system segment is estimated to gain around 222 BPS in its market share by 2026 over 2016. Stereostatic X-ray guided biopsy will drive the guidance system segment through to 2026. Reagents and kits will witness moderate consumption.

Medical Diagnostics Monopolise Application Segment

Based on application type, medical diagnostics will continue to hold a dominant share of over 61% by 2026 end, in terms of revenues. Scientific research, accounting for the rest, will witness an impressively growing CAGR of 6.9% over 2016-2026. This segment is expected to reach beyond US$ 1,008.0 Mn in 2026.

Hospitals Remain Largest End-use Consumer

By end-user, hospitals will continue to contribute nearly 50% share to the market value by 2026 end. This end-use segment will witness a robust CAGR of 8.2%. Diagnostic centres will account for over 23% in 2026 with a slight decline over 2016-2026, whereas specialised oncology centres are anticipated to expand at a CAGR of 6.1% during 2016-2026.

Respiratory Devices Market to Surge at a CAGR of 9.2% by 2027

The global respiratory devices market was valued at nearly US$ 13 billion in 2016. It is projected to grow at 9.2% CAGR during the period 2017-2027 to reach US$ 34.17 billion in revenues.
Demand for respiratory devices will continue to be driven by increasing ageing population and rising prevalence of COPD and obstructive sleep apnea. Increasing emphasis on healthcare spending in developing countries, especially in Asia Pacific and Latin America, will continue to positively influence the growth of the market.

Adoption of non-invasive techniques in pulse oximeters and advancement in full polysomnography testing are also favourably impacting the growth of the market.
Although Future Market Insights maintains a positive outlook on the global respiratory devices market, premium pricing, budgetary constraints, and increasing use of generic product types can impede the growth of the market.

View Report Preview: https://www.futuremarketinsights.com/reports/respiratory-devices-market

The key trends expected to influence the global respiratory devices market in the foreseeable future are,

Portable and wearable devices are steadily gaining popularity among patients owing to ease-of-use and flexibility in carrying the devices.
Growing demand for stationary oxygen concentrator with pulse flow technology and rechargeable batteries.

Increasing demand for respiratory devices in Asia Pacific on account of rising prevalence of chronic obstructive pulmonary diseases. Multinational companies are focusing on consolidating their position in developing countries to leverage upon the emerging opportunities.

Positive Airway Pressure Devices Account for the Highest Demand

According to Future Market Insights’ research, positive airway pressure devices currently account for the highest demand. This segment accounted for nearly 29% revenue share of the market in 2017; by 2027, this is projected to increase to 34.6%. In terms of revenues, positive airway pressure devices segment is projected to reach US$ 11.81 billion in revenues by 2027.

Other key product types by revenue are respiratory consumables (respiratory masks, nasal cannulas, tracheostomy tubes and oxygen tubes) and pulse oximeters.

Future Market Insights also offers market forecast and analysis on other key respiratory devices, including nebulisers, oxygen concentrators, polysomnography devices, mechanical ventilators, and spirometers.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-794

Hospitals Largest End-users

By end-user, the key segments include hospitals, ambulatory surgical centres, clinics, and long-term care centres. Currently, hospitals account for the highest demand for respiratory devices, followed by ambulatory surgical centres and long-term care centres. Demand for respiratory devices from hospitals was worth US$ 5.18 billion in 2016; by 2027, this is projected to grow at 9.8% CAGR to reach US$ 14.36 billion.

U.S. Continues to Account for Significant Percentage of Global Sales
The U.S. remains the largest market for respiratory devices globally. On the back of strong sales in the U.S., the North America respiratory devices market accounted for over 40% revenue share of the market in 2016. Future Market Insights projects North America to remain the largest market for respiratory devices during the period 2017-2027.

Western Europe and APEJ are the other leading markets for respiratory devices. These two markets collectively accounted for a revenue share of over 35% in 2016.
Future Market Insights, in its report, has also profiled the respiratory devices market in Latin America, Eastern Europe, Japan, and MEA.
In its report, companies profiled by Future Market Insights are Massimo Corporation, Teleflex Incorporated, Fisher & Paykel Healthcare Limited, ResMed Inc, Hamilton Medical AG, Medtronic PLC, Koninklijke Philips N.V., Smiths Medical, General Electric Healthcare Limited, Drägerwerk AG & Co. and KGaA, Inogen Inc.

Soft Tissue Repair Market is Expanding at a CAGR of 5.5% by 2022

A new report by Future Market Insights (FMI) anticipates the global soft tissue repair market to exhibit a steady 5.5% CAGR throughout the forecast period (2017-2022). The global market for soft tissue repair is expected to account for over US$ 15,000 Mn revenues by 2022-end.

Advancements in Products such as Bioabsorbable Soft Tissue Screws to Propel Growth of the Market
A number of technological advancements and innovations have been observed in orthopedic connective tissue repair procedures. Novel advances, for instance – the innovative surgical techniques, are being made in the procedures associated with anterior cruciate ligament (ACL) reconstruction, in a bid to make the process more effective. Global leaders, including Zimmer Biomet and NORAKER, have been developing new bioabsorbable soft tissue screws over the past few years. Leading market players have also been focusing on development of the mesh with biological products, which would act as a replacement for human allograft. An example of this is development of EZ Derm by MoInlycke Health Care, utilized as dressing for wounds using wires and pins independently, or together, with various other internal fixation devices. These devices are utilized for surgeries pertaining to hip replacement and spine.

View Report Preview: https://www.futuremarketinsights.com/reports/soft-tissue-repair-market

People across the globe are becoming aware of development, promotion, and commercialization of the advanced platelet-rich plasma devices, used for musculoskeletal disorders. In addition, there is a surge in awareness about skeletally immature patients to have a high risk of tear in the connective tissue and ligaments. These factors might positively impact global demand for soft tissue repair in the near future.

Sports-related Injuries- A Major Factor Driving the Market Growth

A major factor affecting demand for soft tissue repair is injuries related to sports. Athletes usually suffer from ACL tear during the game, or while performing other physical activities. Moreover, increasing aging population is also expected to play an imperative role in growth of the market. With aging, substantial changes are observed in skeletal and neuromuscular systems, which in turn leads towards ACL tear, weak ligaments and arthritis. Prevalence of obesity in geriatric population is directly increasing risk of degenerative bone diseases, such as osteoporosis and osteoarthritis. The aforementioned factors are further expected to increase demand for soft tissue repair procedures.
In contrast, high prices associated with soft tissue repair procedures, lack of awareness in population across underdeveloped and remote regions, and unfavorable reimbursement policies are factors which will impede demand for soft tissue repair procedures in the near future.

APEJ to Witness a Significant Expansion in the Market

The soft tissue repair market in Asia-Pacific excluding Japan (APEJ) is expected to witness a significant growth, with revenues poised to surpass US$ 3,000 Mn by 2022-end. Growth of the market in APEJ can be primarily attributed to increasing purchasing power of population, and rising prevalence of musculoskeletal disorders in countries such as India and China. In addition, North America is expected to remain the most attractive market for soft tissue repair, owing to the hike in healthcare expenditure in this region.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4931

Based on product, sales of laparoscopic instruments, and synthetic mesh are expected to collectively account for over one-third revenue share of the market during the forecast period. Sales of synthetic mesh and laparoscopic instruments will register similar CAGRs through 2022.
Orthopedic Application of Soft Tissue repair to Account for Largest Revenue Share
Orthopedic application of soft tissue repair are expected to account for the largest revenue share of the market during 2017 to 2022, followed by skin repair application. In addition, revenues from orthopedic and skin repair application of soft tissue repair are expected to collectively account for over US$ 7,000 Mn by 2022-end.

Accounting for around two-third revenue share of the market, hospitals are expected to remain the most lucrative end-users in the global market for soft tissue repair. Revenues from hospitals in the market are expected to reach approximately US$ 10,000 Mn by 2022-end.
Key players profiled by the FMI’s report, who are actively operating in the global soft tissue repair market, include Wright Medical Group N.V., Integra LifeScience Corporation, Medtronic Plc., CONMED Corporation, C. R. Bard, Inc., Braun Melsungen AG, Smith & Nephew, DePuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Inc., and Arthrex Inc.

Paediatric Vaccine Market is Expanding at a CAGR of 12.2% by 2026

According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 14.4% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion of healthcare expenditure in the recent times. The paediatric vaccine market is segmented according to indication, technology and vaccine type. According to the indication, the paediatric vaccine market is sub segmented into pneumococcal, DTP, rotavirus, influenza, meningococcal, hepatitis B, Hib, MMR and polio. According to technology the market is further segmented into live or attenuated, inactivated or killed, toxoid, conjugate, subunit and recombinant vaccines. By vaccine type, the global paediatric vaccine market is segmented into monovalent and multivalent vaccines.

View Report Preview: https://www.futuremarketinsights.com/reports/pediatric-vaccines-market

A slew of routine immunisation initiatives rolled out by the government and private agencies has broadened the market for the paediatric vaccines. A new wave of funds pumped into the market by different government and private players to cork the rise of the child deaths across the globe has also opened a new window of opportunity for the paediatric vaccine market. As per the report of WHO (World Health Organization), the global spending on immunisation soared from US$21.4 to US$26.9 per infant in 2014. The massive economic boom in some regions of the world is expediting the growth of the paediatric vaccine market.

Segmentation analysis

• By indication, pneumococcal segment accounted for higher revenue share in global paediatric vaccines as compared to other product segments. The pneumococcal segment is expected to reach a value of US$ 31.58 Bn by 2026, reflecting a CAGR of 14.4% over the forecast period. The growth of pneumococcal segment is attributed to the increasing incidence of infectious diseases.
• In terms of revenue, Hib vaccine segment is the second most growing segment and is expected to reach a value of US$ 13.49 Bn by 2026, growing at a CAGR of 13.4%. Hepatitis B and meningococcal segment are expected to show double-digit CAGR growth in the forecast period contributing to the growth of global paediatric vaccine market.
• By technology, conjugate segment accounted for highest revenue share in global paediatric vaccine market as compared to live or attenuated segment. The conjugate segment is expected to reach a value of US$ 32.09 Bn by 2026, reflecting a CAGR of 14.8% over the forecast period. This is expected to be closely followed by the growth of pneumococcal and meningococcal vaccines in this segment
• By end user, institutional health centres account for higher demand for paediatric vaccine as compared to other end user segments such as hospital pharmacies and retail pharmacies. The strong growth in institutional health centres can be attributed to increasing government interventions in immunisation programs in order to improve vaccine coverage. Institutional health centres are expected to register highest CAGR of 13.8% over the forecast period.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1317

Regional analysis

By region, North America is dominating the global paediatric vaccine market due to improved healthcare infrastructure in this region. The North America paediatric vaccine market is expected to be valued at US$ 20.15 Bn by 2026 growing at a CAGR for 11.0%. In addition to North America, demand for paediatric vaccines has been significantly growing in Western Europe and APEJ. APEJ is expected to grow at a CAGR for 14.9% over the forecast period and is expected to dominate the market by 2026 by generating revenue of US$ 22.69 Bn and revenues in Western Europe are anticipated to grow by 11.2%. Middle East and Africa is expected to grow at a CAGR of 12.6% and this growth is anticipated by growth government intervention for immunisation by carrying out national level immunisation campaigns and also disease specific immunisation campaigns.

Vendor insights

Key players in the global paediatric vaccine market include Indian Immunologicals, GlaaxoSmithKline Plc., Pfizer Inc., Sanofi, Merck & Co. Inc., Panacea Biotec, Zydus Cadila, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., and Bharat Biotech. The growth of paediatric vaccine market is attributed to the development in the research by key players in the field, for instance, in February 2016, GSK submitted US regulatory submission for expanding the indication of FLuLaval Quadrivalent, influenza vaccine, for infants more than 6 months. These developments will boost the growth of the global paediatric vaccine market.